D
Daniel Altman
Researcher at Karolinska Institutet
Publications - 104
Citations - 4961
Daniel Altman is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Urinary incontinence & Hysterectomy. The author has an hindex of 38, co-authored 104 publications receiving 4530 citations. Previous affiliations of Daniel Altman include University of Milano-Bicocca & Uppsala University.
Papers
More filters
Journal ArticleDOI
Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse.
Daniel Altman,Tapio Väyrynen,Marie Ellström Engh,Susanne Maigaard Axelsen,Christian Falconer +4 more
TL;DR: Compared with anterior colporrhaphy, use of a standardized, trocar-guided mesh kit for cystocele repair resulted in higher short-term rates of successful treatment but also in higher rates of surgical complications and postoperative adverse events.
Journal ArticleDOI
Ovarian Cancer Risk After Salpingectomy: A Nationwide Population-Based Study
TL;DR: The results suggest that removal of the fallopian tubes by itself, or concomitantly with other benign surgery, is an effective measure to reduce ovarian cancer risk in the general population.
Epidemiology of urinary incontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal incontinence (AI)
Ian Milsom,Daniel Altman,Rufus Cartwright,MC Lapitan,R Nelson,Ulla Sillén,Kari A.O. Tikkinen +6 more
Journal ArticleDOI
Late adverse effects of short-course preoperative radiotherapy in rectal cancer.
Johan Pollack,Torbjörn Holm,Björn Cedermark,Daniel Altman,Bo Holmström,Bengt Glimelius,Anders Mellgren,Anders Mellgren +7 more
TL;DR: The aims of this study were to compare long‐term morbidity and quality of life in patients undergoing rectal cancer surgery with or without preoperative radiotherapy.
Journal ArticleDOI
Anal incontinence after vaginal delivery: a five-year prospective cohort study.
TL;DR: Anal incontinence among primiparous women increases over time and is affected by further childbirth, particularly at 9 months postpartum, which is an important predictor of persisting symptoms.